394 results on '"Rizzetto, M."'
Search Results
2. C13/12 CHOLANGIOGRAFIC FINDINGS RELATED TO HEPATIC ARTERY STENOSIS IN ORTHOTOPIC LIVER TRANSPLANTATION (OLT) PATIENTS
3. C11/12 LIVER IRON STORES IN PATIENTS WITH HEPATOCELLULAR CARCINOMA DEVELOPED ON A CIRRHOTIC LIVER
4. C03/31 LIVER IRON DISTRIBUTION AND BLOOD IRON INDICES IN CANDIDATES FOR OLT
5. C01/089 CLINICAL PATTERNS OF HCV - RELATED CRYOGLOBULINEMIC PATIENTS
6. GS1/001 CORRELATIONS BETWEEN VIROLOGIC AND HISTOLOGIC RESPONSES IN CHRONIC HEPATITIS C PATIENTS: ANALYSES FROM A LARGE INTERNATIONAL COMPARATIVE STUDY OF ALPHA-INTERFERON THERAPY
7. Portal Vein Thrombosis Relevance on Liver Cirrhosis: Italian Venous Thrombotic Events Registry
8. Basal values and on treatment decline of hepatitis B core-related antigen are predictive of response to interferon therapy in chronic hepatitis D
9. Role of hepatitis B core-related antigen and antibodies to hepatitis B core antigen level in the natural history of chronic HBV infection
10. Therapy with direct acting antivirals in patients with hepatitis C virus related lymphoproliferative disorders and mixed cryogloglobulinemia
11. Diversity of clinical presentation and virological characteristics of hepatitis delta in different regions world-wide: results of the Hepatitis Delta International network
12. Markedly improvement of glycaemic control in diabetic patients with chronic hepatitis C achieving sustained virologic response after direct acting antiviral therapy: results of a prospective controlled study
13. Impact of IL28B genotype on response rates in hepatitis C virus cirrhotic patients treated with new DAA regimens: experience of a single center
14. Declining prevalence and increasing awareness of hepatitis C virus infection in Italy: a population-based survey
15. High Efficacy of Ledipasvir/Sofosbuvir Plus Ribavirin among Patients with Decompensated Cirrhosis who Underwent Liver Transplant during Participation in the Solar-1 and -2 Studies
16. Analysis of Hemodynamic Effects of Bosentan on Portopulmonary Hypertension in Short-Term and Medium-Term Follow-Up: Promising Predictors of Response to Therapy?
17. Stereotactic Ablative Radiotherapy in the Treatment of Hepatocellular Carcinoma Lesions Larger than 3 Centimeters
18. A Novel Approach for Hepatitis Delta Virus Viremia Quantification by Droplet Digital PCR Assay
19. Add-On Peginterferon Alfa-2a Significantly Reduces HBsAg Levels in HBeAg-Negative, Genotype D Chronic Hepatitis B Patients Fully Suppressed on Nucleot(s)ide Analogues Treatment: Final Results of the Hermes Study
20. All Oral Sofosbuvir-Based Antiviral Therapy in Liver Transplant Recipients Affected by Moderate-Severe Hepatitis C Recurrence: Predictors of Viral Response and Survival
21. FRI-275 - Role of hepatitis B core-related antigen and antibodies to hepatitis B core antigen level in the natural history of chronic HBV infection
22. FRI-259 - Basal values and on treatment decline of hepatitis B core-related antigen are predictive of response to interferon therapy in chronic hepatitis D
23. P1056 : Insulin resistance and liver damage are associated with early signs of left ventricular systolic dysfunction in patients with nonalcoholic fatty liver disease, independently of diabetes, hypertension and dyslipidemia
24. P1058 : Increased epicardial fat and early signs of impaired diastolic and systolic left ventricular function in non-diabetic, non-dyslipidemic, normotensive patients with Nonalcoholic Fatty Liver Disease
25. P0364 : Clinic evaluation of circulating micrornas as potential biomarkers of hepatocellular carcinoma in patients with HBV chronic infection
26. P0519 : Lipidomics reveals that low plasma unsaturated to saturated fat ratios are biomarkers of NAFLD and liver damage
27. P1042 : Deregulation of de novo lipogenesis can be associated with liver damage in patients with non alcoholic fatty liver disease
28. P0069 : Risk factors for metabolic syndrome after liver transplantation: What has changed over time
29. LP25 : Add-on peginterferon ALFA-2A significantly reduces hbsag levels in hbeag-negative, genotype d chronic hepatitis b patients fully suppressed on nucleot(s)ide analogue treatment: The hermes study
30. P0060 : Antiviral therapy with sofosbuvir plus ribavirin in HCV-infected cirrhotic patients awaiting liver transplantation: Preliminary data from a single-centre experience
31. P0063 : Sofosbuvir plus ribavirin for the treatment of severe hcv recurrence after liver transplantation: Preliminary data from a single-centre experience
32. P843 ALTERATION IN GLUCOSE METABOLISM AFTER AN ORAL GLUCOSE LOAD AND RELATIONSHIP WITH LIVER DAMAGE IN PATIENTS WITH NAFLD
33. P1028 NON-INVASIVE SCORE SYSTEM FOR FIBROSIS (NISF) IN CHRONIC LIVER DISEASE: A NEW MODEL COMBINING BIOCHEMICAL, ELASTOGRAPHIC AND ULTRASOUND DATA
34. P1209 FACTORS INFLUENCING RENAL FUNCTION IN PATIENTS RECEIVING TELAPREVIR TWICE DAILY OR EVERY 8 HOURS: RESULTS FROM THE PHASE III OPTIMIZE STUDY
35. P845 IMPACT OF FAT VERSUS GLUCOSE LOAD ON OXIDATIVE STRESS IN NON-ALCOHOLIC FATTY LIVER DISEASE
36. P1187 A CONCENTRATION-DEPENDENT PHARMACOKINETIC INTERACTION WITH TELAPREVIR INCREASES RIBAVIRIN CONCENTRATIONS AND LEADS TO HIGHER HAEMOGLOBIN DROP
37. P1120 PREDICTION OF SUSTAINED VIROLOGIC RESPONSE IN TREATMENT-NAIVE CHRONIC HEPATITIS C GENOTYPE 1 PATIENTS TREATED WITH TELAPREVIR PLUS PEGYLATED INTERFERON AND RIBAVIRIN IN PHASE 3 TRIALS
38. P995 SORAFENIB VERSUS Y-RADIOEMBOLIZATION FOR ADVANCED MONO-LOBAR HEPATOCELLULAR CARCINOMA IN CIRRHOTIC PATIENTS: A PRELIMINARY STUDY ON TOLERABILITY AND SURVIVAL
39. P1078 PREDICTION OF EVS PRESENCE BY CALCULATED RISK SCORES IN B-VIRAL CIRRHOSIS
40. P1158 EFFICACY AND SAFETY OF BOCEPREVIR-BASED THERAPY IN HCVG1 TREATMENT-EXPERIENCED PATIENTS WITH ADVANCED FIBROSIS/CIRRHOSIS: THE ITALIAN AND SPANISH NPP EARLY ACCESS PROGRAM
41. P917 PORTAL VEIN THROMBOSIS IN CIRRHOTIC PATIENTS UNDERGOING ORTHOTOPIC LIVER TRANSPLANTATION: A SINGLE CENTRE EXPERIENCE
42. P849 QUANTITATIVE AND QUALITATIVE ANALYSIS OF PLASMA FREE FATTY ACIDS AND THEIR IMPACT ON LIVER DAMAGE IN NAFLD PATIENTS
43. P840 ALTERATION IN LIPID METABOLISM AFTER AN ORAL FAT LOAD IN PATIENTS WITH NAFLD
44. SAT-119 - High Efficacy of Ledipasvir/Sofosbuvir Plus Ribavirin among Patients with Decompensated Cirrhosis who Underwent Liver Transplant during Participation in the Solar-1 and -2 Studies
45. FRI-069 - Stereotactic Ablative Radiotherapy in the Treatment of Hepatocellular Carcinoma Lesions Larger than 3 Centimeters
46. FRI-445 - All Oral Sofosbuvir-Based Antiviral Therapy in Liver Transplant Recipients Affected by Moderate-Severe Hepatitis C Recurrence: Predictors of Viral Response and Survival
47. FRI-436 - Analysis of Hemodynamic Effects of Bosentan on Portopulmonary Hypertension in Short-Term and Medium-Term Follow-Up: Promising Predictors of Response to Therapy?
48. THU-105 - A Novel Approach for Hepatitis Delta Virus Viremia Quantification by Droplet Digital PCR Assay
49. LBP521 - Add-On Peginterferon Alfa-2a Significantly Reduces HBsAg Levels in HBeAg-Negative, Genotype D Chronic Hepatitis B Patients Fully Suppressed on Nucleot(s)ide Analogues Treatment: Final Results of the Hermes Study
50. 919 ANEMIA AND ITS MANAGEMENT IN PATIENTS TREATED WITH TELAPREVIR TWICE DAILY VERSUS EVERY 8 HOURS IN THE PHASE III OPTIMIZE STUDY
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.